InCube Ventures
VC Fund
San Jose, United States
InCube Ventures is a VC fund in San Jose focused on Health Care and Biotechnology. DFJ InCube Ventures is a life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. The fund is built around Mir Imran, one of the leading healthcare innovators. Under Mir's leadership, DFJ InCube Ventures has access to ventures formed by InCube Labs – amulti-disciplinary research lab that has been a highly productive source of medical device companies. Mir and InCube Labs have formed 20 companies over the past 25 years, creating a series of multi-billion dollar markets along the way. In addition to Mir, proven healthcare entrepreneurs and investors Andrew Farquharson and Wayne Roe serve as managing partners of the fund.DFJ InCube Ventures managing partners work closely with entrepreneurs to commercialize breakthroughs grounded in clinical need and protected by strong intellectual property. Their experienced team also actively helps young companies mitigate technical, clinical and reimbursement risks. Most importantly, the team collaborates with entrepreneurs to determine the most effective path for bringing innovations to life in a way that dramatically improves clinical outcomes.The fund's current portfolio includes companies that are developing novel treatment approaches in clinical areas such as atrial fibrillation, epilepsy, gastro intestinal surgery, iron-deficiency anemia, hemorrhagic stroke and metabolic disorders.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $55M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries InCube Ventures invests in
Stages InCube Ventures invests in
Countries InCube Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bill Ringo
|
|||
Mar Perez
|
|||
Wayne Roe
|
|||
Andrew Farquharson
|
|||
| See all 7 contacts → | |||
Investment Focus
Industry
- Health Care 11 (58%)
- Biotechnology 8 (42%)
- Medical Device 5 (26%)
- Medical 3 (16%)
- Wellness 2 (11%)
Stage
- Series B 6 (32%)
- Series C 3 (16%)
- Series A 2 (11%)
- Series D 2 (11%)
- Funding Round 2 (11%)
Country
- United States 12 (63%)
- Denmark 1 (5%)
- Ireland 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bill Ringo
Member
|
Member | Total investments: 0 | Find email | |
|
Mar Perez
Principal
|
Principal | Total investments: 0 | Find email | |
|
Wayne Roe
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Adam Lin
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Andrew Farquharson
Managing Director & Co-founder
|
Managing Director & Co-founder | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tasso
|
Tasso is revolutionizing blood-based diagnostics by placing the user at the center of the diagnostics process. Patients are able to sample their own blood in the comfort of their home with a device that is safe, simple, and convenient. | $100M / Series B / Dec 16, 2021 | |
Neuros Medical
|
Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | $38.5M / Series B / Jan 07, 2021 | |
Metagenomi
|
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. | $75M / Series A / Nov 12, 2020 | |
Neptune Medical
|
Neptune Medical is a venture capital funded medical device start-up, located in the Silicon Valley town of Burlingame. they develop, manufacture, and commercialize high-volume, high clinical utility, single use medical devices for gastroenterology. they believe that our patent-pending technology is foundational and will have a broad impact acrossmultiple additional clinical areas, including cardiovascular and flexible robotic surgery procedures. | Venture - Series Unknown / May 26, 2020 | |
|
Metagenomi
|
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. | $26.4M / Series A / Aug 16, 2019 | |
|
Metagenomi
|
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. | Seed / Feb 28, 2019 | |
WhiteSwell
|
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure . | $30M / Series B / Dec 11, 2018 | |
Fe3 Medical
|
Fe3 Medical Inc. engages in commercialization of a drug delivery technology that enables the safe, non-toxic transport of approximately 10 milligrams of iron across the skin for those who suffer with iron-deficiency anemia. | $3.5M / Series B / Aug 08, 2016 | |
Channel Medsystems
|
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies. The company is developing proprietary cryo-ablation delivery technologies. They strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers.Channel Medsystems was founded in 2009 and headquartered in San Francisco, California. | $22M / Series C / Sep 22, 2015 | |
PLEXUSS
|
PLEXUSS is a high-growth education technology company that is changing the world by leveraging its Global Student Network to connect millions of students everywhere with real opportunity. We connect thousands of qualified students with life-changing educational opportunities daily.PLEXUSS’ exclusive social technology, matching algorithms, bigdata analytics, and Microsoft Accelerator recognized machine learning help students globally connect with most compatible post-secondary educational opportunities, engaging content, and other students. | Angel / Jun 01, 2015 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does InCube Ventures invest in?
InCube Ventures invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series B and Series C stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact InCube Ventures?
Public channels for InCube Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at InCube Ventures?
The team at InCube Ventures includes Bill Ringo (Member), Mar Perez (Principal) and Wayne Roe (Managing Director), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
